Squarepoint’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
5152
2025
Q4
Hold
0
5064
2025
Q3
Sell
-55,355
Closed -$1.65M 5127
2025
Q2
$1.47M Sell
55,355
-383,576
-87% -$10.1M ﹤0.01% 2330
2025
Q1
$10.6M Buy
438,931
+171,626
+64% +$5.42M 0.03% 995
2024
Q4
$10.8M Buy
267,305
+233,051
+680% +$13.3M 0.03% 1105
2024
Q3
$2.17M Sell
34,254
-107,566
-76% -$6.31M 0.01% 2011
2024
Q2
$7.52M Buy
+141,820
New +$9.3M 0.03% 1106
2024
Q1
Sell
-50,603
Closed -$942K 4764
2023
Q4
$942K Buy
50,603
+23,673
+88% +$310K ﹤0.01% 2561
2023
Q3
$298K Buy
+26,930
New +$385K ﹤0.01% 3171
2023
Q2
Sell
-26,063
Closed -$434K 4093
2023
Q1
$434K Buy
+26,063
New +$269K ﹤0.01% 2384
2022
Q4
Sell
-14,382
Closed -$39K 3665
2022
Q3
$39K Sell
14,382
-381
-3% -$1.25K ﹤0.01% 2879
2022
Q2
$43K Sell
14,763
-3,077
-17% -$7.62K ﹤0.01% 2721
2022
Q1
$54K Sell
17,840
-50,279
-74% -$180K ﹤0.01% 2674
2021
Q4
$313K Buy
68,119
+37,704
+124% +$211K ﹤0.01% 2424
2021
Q3
$191K Sell
30,415
-68,751
-69% -$425K ﹤0.01% 2511
2021
Q2
$594K Sell
99,166
-7,089
-7% -$42.1K ﹤0.01% 2016
2021
Q1
$672K Buy
106,255
+61,907
+140% +$436K 0.01% 1806
2020
Q4
$250K Sell
44,348
-55,336
-56% -$335K ﹤0.01% 2359
2020
Q3
$580K Buy
+99,684
New +$686K 0.01% 1319
2020
Q1
Sell
-110,347
Closed -$885K 2566
2019
Q4
$885K Buy
110,347
+29,868
+37% +$218K 0.01% 1414
2019
Q3
$554K Sell
80,479
-55,239
-41% -$410K 0.01% 1565
2019
Q2
$1.13M Buy
135,718
+85,118
+168% +$727K 0.01% 1194
2019
Q1
$503K Sell
50,600
-25,343
-33% -$212K 0.01% 1484
2018
Q4
$581K Buy
+75,943
New +$908K 0.01% 1171

Other funds holding VKTX